Home›Companies›Healthcare›EarliPoint Health

EarliTec Diagnostics, Inc.

Autism assessment device for clinicians evaluating young children.

Updated Nov 10, 2026·Latest SEC filing Apr 30, 2026·Suggest an edit

About EarliPoint Health

EarliPoint Health is a private company based in Decatur, Georgia. It has reported $30,499,998 raised in three offerings on Form D since February 2022. Its chief executive is Jim Grien.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Apr 15, 2026Apr 30, 2026$3,500,000of $7.0M target3$1.1MDebtRule 506(b)Form D ↗
Mar 19, 2024Apr 2, 2024$21,499,998of $36.0M target5$4.2MEquityRule 506(b)Form D ↗
Feb 4, 2022Feb 18, 2022$5,500,000of $19.5M target3$1.8MEquityRule 506(b)Form D ↗
Total, three offerings$30,499,998

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on EarliPoint Health's Form D filed Apr 30, 2026.

Jim Grien
Jim Grien
President & CEO, TM Capital Corp, director
JA
James Adox
Director
Also a director at HistoSonics.
Maria Kousi
Maria Kousi
Director
Kurt Jacobus
Kurt Jacobus
Chairman of the Board
Also a director at Codoxo, CurvaFix and Huxley Medical.
Jamie Pagliaro
Jamie Pagliaro
President & Chief Executive Officer, director
Neil Hattangadi
Neil Hattangadi
CEO & Co-Founder, Cortica, director

Earlier filings also listed William Marks (director, last listed Apr 2024), Thomas Ressemann (ceo and director, last listed Apr 2024), Jones Warren (excludes normal compensation for officers and directors, last listed Feb 2022) and Jack Griffis (director, last listed Feb 2022).

Sources

  1. SECEarliTec Diagnostics, Inc. filing history
  2. CompanyAbout EarliPoint Health